Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy - Dugas-Breit, Susanne; Forschner, A.; Erdmann, M.; Gutzmer, R.; Kähler, K. C.; Holst, I.; Brekner, A.; Franklin, C.; Sindrilaru, A.; Zimmer, L.; Heinzerling, L.; Utikal, Jochen; et al. (European journal of cancer, 2026)
Online verfügbar: 29. November 2025, Artikelversion: 11. Dezember 2025